On the other hand, many different metastatic tumors upregulate the PD-L1 expression to take an advantage of the negative regulation of the T cell immune system by the immune checkpoint molecules [9,10,11,12,13], and the PD-L1-overexpressed tumors may be associated with poor prognosis [14,15,16]. The gene discussed is CD274; the disease is metastatic neoplasm.